Ebit تغيير تاريخ
Agenus USD 15.05M 656K 2026-03
AstraZeneca USD 4.66B 1.5B 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Celldex Therapeutics USD -80.62M 3.81M 2026-06
Eisai JPY 16.7B 8.03B 2026-09
Merck USD 7.33B 6.49B 2026-09
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Pfizer USD 4.85B 5.03B 2026-09
Plus Therapeutics USD -7.12M 1.38M 2026-03
Roche Holding CHF 11.46B 1.91B 2026-06